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Executive Summary 
Domestic violence and abuse (DVA) is recognised as a significant global public health 
issue (World Health Organisation (WHO) 2013). DVA is a serious, multifaceted societal 
issue with profound health and mental wellbeing consequences with the potential for 
longer term health care needs in supporting survivors. The Office for National Statistics 
(2015) crime survey for 2013-2014 estimates that at least 1.4 million women and 
700,000 men aged between 16 and 59 experienced DVA in England and Wales equating 
to 8.5% of women and 4.5% of men reporting a DVA crime (ONS, 2015). Furthermore, 
new data reports that 85% of DVA victims sought help, on average five times from 
professionals, including healthcare professionals, in the year before they received 
effective help (Safe Lives 2015). The cost to public services of domestic abuse (uprated 
to 2013 prices) is £4.3 bn with the majority of costs attributed to the health service 
(£1.9 bn) (Walby 2004, 2009). 
 
In 2011 the findings from a cluster randomised controlled trial (RCT); funded by the 
Health Foundation, for the Identification and Referral to Improve Safety (IRIS) 
programme was published in The Lancet (Feder et al., 2011). The trial was based on two 
urban primary care Trusts; Bristol and Hackney in London with a total of 48 general 
practices involved in the study from 2007 - 2010. The IRIS intervention programme 
comprises of a structured approach to support and management of DVA by providing 
training to clinical and non-clinical staff located within GP surgeries, ongoing consultancy 
to the practice team, a prompt within the patient’s medical records and a defined referral 
pathway to an advocate educator (AE) working locally. In November 2010 the IRIS 
National Steering group was formed.  The current membership of this group comprises 
Donna Covey (Chair) – CEO, AVA, Professor Gene Feder – University of Bristol, Carol 
Metters – CEO, Next Link, Karen Ingala-Smith – CEO, nia, Val Lunn – CEO, WAIS, Dr. 
Roxane Agnew Davis – DVTraining Ltd. The IRIS DVA intervention model has received 
national recognition and strategic relevance in over seven key UK documents on 
domestic violence and abuse.   
This independent review of the national IRIS intervention is based on national and local 
data that is widely available since the publication of the IRIS RCT study (Feder et al., 
2011). This report has been conducted independently of the national IRIS steering group 
but in consultation as part of the review process to compile this report for the 
Department of Health (DOH) 3 year funding criteria (2013 – 2016). 
The review is solely based on the literature available at the time of submitting this report 
(June 2016) and includes the annual IRIS data reports (2013, 2014, 2015) published 
peer review articles (Feder et al., 2011, Devine et al., 2012), local IRIS service 
evaluations (5 independent reports) from commissioned IRIS sites and an evaluation of 
the IRIS train the trainers report.   
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Background to Domestic Violence and Abuse (DVA) 
DVA is recognised as a significant global public health issue (World Health Organisation 
(WHO) 2013). DVA is a serious, multifaceted societal issue with profound health and 
mental wellbeing consequences with the potential for longer term health care needs in 
supporting survivors. The Office for National Statistics (2015) crime survey for 2013-
2014 estimates that at least 1.4 million women and 700,000 men aged between 16 and 
59 experienced DVA in England and Wales equating to 8.5% of women and 4.5% of men 
reporting a DVA crime (ONS, 2015). By contrast the British crime survey 2001-2002 
showed only 35% of DVA cases were reported to the police but by 2008-2009 this figure 
had increased to 47% (Walker et al., 2009).  Whilst this indicates a rise in the number of 
DVA cases that are then investigated and recorded as a crime these figures do not 
included cases that go unrecorded or fail to get a prosecution nor does it record violent 
crime resulting from domestic incidents.   
  
Furthermore, new data reports that 85% of DVA victims sought help, on average five 
times from professionals, including healthcare professionals, in the year before they 
received effective help (Safe Lives 2015). Coy & Kelly (2011) when conducting an 
evaluation of four independent DVA advocacy schemes reported that female victims of 
DVA will sustain, on average, 35 episodes of abuse before seeking any form of help 
including discussing DVA with healthcare professionals (Coy & Kelly 2011).  
 
In earlier work by Ramsay et al., (2006) and Richardson et al., (2001) they report poor 
or inappropriate responses by healthcare professionals to patients who have experienced 
DVA (Richardson et al., 2001).  In the systematic review conducted by Ramsay et al., 
(2006) they found that clinicians are often unaware of the referral pathways for DVA 
survivors or have not received any training around DVA. Whilst in some areas of the UK 
specialist DVA training is provided, particularly in acute and ED settings (Hinsliff-Smith & 
McGarry, 2016, McGarry 2016, Basu & Ratcliffe 2014) there is little evidence of work 
undertaken in primary care (Feder et al., 2006). In economic terms the cost to public 
services of domestic abuse (uprated to 2013 prices) is reported to be £4.3 billion with 
the majority of costs attributed to the health service (£1.7 billion) which includes acute, 
community and primary care (Walby 2004, 2009). 
 
In February 2014 the National Institute for Health and Care Excellence (NICE) published 
detailed guidance and it is explicit that all agencies, including healthcare providers, have 
a central role in the prevention and management of DVA. Front line healthcare 
professionals, including those working in primary healthcare should receive targeted 
education and continual professional development in order to support and manage DVA 
(NICE 2014). It is known that those who experience DVA report significant immediate 
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and longer-term health impacts which affect both physical and mental health status 
(McGarry et al. 2011).   The detrimental effect on an individual’s mental health either 
from experiencing DVA or witnessing DVA (i.e. as a child or family member) is becoming 
well documented in the literature (Trevillion et al., 2012).  It is only more recently 
considerations have been given to the magnitude and extent of DVA including post-
traumatic stress disorder (PTSD), depression, anxiety (Coid et al., 2003, Golding, 1999) 
and self-harm (Boyle et al., 2006).  In 2012 the UK Home Office published an extended 
definition of DVA to include psychological abuse, and coercive and controlling 
behaviours. This change in the definition indicates recognition of the extent of DVA 
including ‘psychological, physical, sexual, financial, and emotional’ and may result in a 
more comprehensive understanding of DVA including rates of prevalence in the UK and 
mental health conditions.   
 
The current UK Home Office definition for DVA is: 
…Any incident or pattern of incidents of controlling, coercive or threatening 
behaviour, violence or abuse between those aged 16 or over who are or have been 
intimate partners or family members regardless of gender or sexuality. This can 
encompass but is not limited to the following types of abuse: psychological, physical, 
sexual, financial, emotional […] includes so called ‘honour’ based violence, female genital 
mutilation (FGM) and forced marriage, and is clear that victims are not confined to one 
gender or ethnic group (Home Office, 2012). The aspect of controlling or coercive 
behaviour in intimate or familial relationships was further enhanced with The Serious 
Crime Act (2015) creating a new criminal offence (Home Office 2015).   
 
In 2014, after extensive consultation including the direct involvement of the IRIS 
national steering group, NICE produced guidelines for the support and management of 
DVA across all healthcare settings and support services (2014).  NICE further expanded 
these guidelines with the issuing of the NICE Quality Standards for DVA (2016). The new 
quality standards aim to improve structure, process and outcomes of care for people 
affected by DVA.  The quality statements should have the following impact for patients: 
 
People presenting to frontline staff with possible indicators of DVA are asked about their 
experiences in a private discussion: This may help them talk about DVA, know they are 
not alone, feel that they will be believed and that their experience is not unusual.  They 
will be offered help and support. (DVA 2014 NICE guideline PH50, recommendation 6) 
People experiencing DVA receive a response from level 1 or 2 trained staff : Are helped 
to talk about their experience by trained staff, to know they are not alone, that they can 
get help and support that their experience is not unusual and they will be believed.  
People experiencing DVA are offered referral to a specialist support service: Such as 
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refuges this will mean they can get the help and support they need. 
(DVA 2014 NICE guideline PH50, recommendation 6) 
People who disclose that they are perpetrating DVA are offered a referral to specialist 
services: Are offered referral to specialist services that can help them to change their 
views and understand more about violence. These specialist services can make it easier 
for them to get the help and support they need to change their behaviour. 
(DVA 2014 NICE guideline PH50, recommendation 4, 5, 6, 10 & 14) 
IRIS - Identification and Referral to Improve Safety Programme 
IRIS is a general practice based DVA programme to support staff working within General 
Practice (GP) surgeries.  The IRIS programme includes all levels of clinical staff as well 
as administrative staff (for example reception staff, administrators). The core 
programme includes training and ongoing education, delivered with two sessions for 
clinical staff and one session for non-clinical staff, identified care pathways and an 
enhanced referral route to specialist DVA service for women. The IRIS programme also 
provides information and signposting for male victims and perpetrators. In addition, the 
original IRIS trial utilised the electronic patient medical records to record disclosures or 
concerns about DVA. Use of such a system is well recognised within other settings, i.e. 
Emergency and Accident (Basu & Ratcliffe, 2014). This proven system (Feder et al., 
2011) directly alerts those accessing the patient healthcare system to be aware of the 
patient history within their consultation.  
The core programme is delivered by Advocate Educators (henceforth AE) who work 
alongside third sector specialist organisations working closely with local GP surgeries, 
each programme has a clinical lead (usually a GP working at a practice from the clinical 
commissioning group (CCG) locally). The third sector organisations who are, in the most 
part, commissioned by the local CCG/s or Public Health teams are predominately 
specialist violence against women and girls (VAWG) organisations, for example Women’s 
Aid or other specialist DVA services (for example in Bristol Next Link). 
The IRIS programme and model of intervention model has received national recognition 
and strategic relevance in over seven key UK documents on domestic violence and 
abuse. These include: 
 Royal College of General Practitioners (RCGP).  The IRIS commissioning 
guidance is endorsed by the RCGP and the IRIS model is also highlighted in the 
RCGPs e-learning module on Violence Against Women and Children (VAWC). 
 Department of Health taskforce report from the domestic violence subgroup, 
‘Responding to violence against women and children: The role of the NHS’.  IRIS 
is cited as best practice within this report.   
 Department of Health ‘Commissioning services for women and children who 
experience violence or abuse – a guide for health commissioners’.  IRIS is 
recommended in this report. 
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 Home Office published ‘Domestic Homicide Reviews – Common Themes 
Identified as Lessons to be learned’. IRIS is cited as an example of action that 
can be taken locally to improve provision regarding training and awareness of 
domestic violence and abuse and appropriate follow up for cases and disclosures 
of such abuse. 
 National Institute for Care and Health Excellence (NICE) guidance on 
'Domestic violence and abuse:  how health services, social care and the 
organisations they work with can respond effectively'.  The IRIS model is 
described in recommendations 15 & 16 of the guidance on how to respond 
effectively to Domestic Violence and Abuse and NICE Quality standards have 
recently been published to support these. 
 Home Office ‘Modern Crime Prevention Strategy’ 2016.  The IRIS model is 
promoted in this strategy. 
 Government’s VAWG strategy 2016-2020.  IRIS is recommended as an 
effective intervention which enables early identification and intervention for 
victims/survivors of domestic violence and abuse.  
  
Evidence Base 
Local implementation of IRIS is based on the learning from the initial IRIS research in 
Bristol and Hackney http://www.health.org.uk/publications/iris-case-study/. Evidence of 
the effectiveness of this approach has been demonstrated in a randomized controlled 
trial (RCT) where the intervention proved to be cost effective and also have the potential 
to be a cost saving measure. For details of the trial and for further information about 
IRIS please refer to the IRIS website for details: http://www.irisdomesticviolence.org.uk 
Aims, objectives and Outcomes of the IRIS programme within the local CCG 
context 
Aim: To improve the identification of and response to patients who are affected by 
domestic violence and abuse across general practices.  
Objectives:  
 Increase knowledge of general practice staff about DVA and the help available for 
those patients affected 
 Improve the confidence of general practice staff to ask questions about possible 
abuse in a safe way 
 Make appropriate referrals resulting in improved patient care  
 Improve the recording of DVA in the patients’ medical notes 
 Increase the number of patients referred from general practices for help with 
DVA  
 Improve data collection and analysis of the number of disclosures and referrals  
 Improve the safety of patients by reducing repeat victimisation 
 
 
 
Outcomes 
 
To contribute towards 
 
Domain 1 of the Public Health Outcomes Framework - Improving the wider determinants 
of health in relation to ‘Domestic Abuse’ and Domain 4 Healthcare public health and 
preventing premature mortality  
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Indicator - mortality from causes considered preventable 
 
Domain 1 of NHS Outcomes Framework – Preventing people dying prematurely  
CCG plans regarding Quality Innovation Productivity and Prevention 
 
Delivery of the NHS Mandate through working in partnership so as to reduce violence, 
improve the way the NHS shares information about violence and support victims of crime  
 
Summary findings: 
The completed IRIS review will comprise five themes: 
 Overview of the national IRIS training programme 2013 - 2016 
 IRIS referral data 2013 -2016 
 SWOT analysis 
 Challenges for the national IRIS model going forward 
 Review limitations  
Overview of national IRIS training programme 2013 – 2016 
The IRIS National Implementation Managers produce annual data reports 
(2013/2014/2015) which are widely distributed and will be made freely accessible on the 
IRIS web site www.irisdomesticviolence.org.uk. In addition, further documents were 
accessed and included in this review: 
Feder G. Agnew Davies A. Baird K. Dunne D. Eldridge S. Griffiths C. Gregory A. Howell A. 
Johnson M. Ramsay J. Rutterford C. Sharp D. (2011) Identification and Referral to 
Improve Safety (IRIS) of women experiencing domestic violence with a primary care 
training and support programme a cluster randomised controlled trial. Lancet 378:1788-
95 
Devine A. Spencer A. Eldridge S. Norman R. Feder G. (2012). Cost-effectiveness of 
Identification and Referral to Improve Safety (IRIS), a domestic violence training and 
support programme for primary care: a modelling study based ibn a randomised 
controlled trial. BMJ Open 2:e001008. Doi:10.1136/bmjopen-2012-001008 
Silburn & Silburn (2013) The Nottingham IRIS project   
Granville (2014) Hearing voices of the IRIS service users 
Taylor (2014) The IRIS Project: An evaluation of the Train the Trainers Induction Course  
Downes (2015) IRIS Service South Gloucestershire – Review Report 
Hinsliff-Smith (2015) Mansfield and Ashfield IRIS service evaluation report 
Hinsliff-Smith (2016) Nottingham West service IRIS service evaluation report  
T4T Evaluation (2016) 
CLAHRC evaluation of five of the NE London IRIS sites (2016) 
IRIS Strategic relevance document (2016) 
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In total all these documents provide a useful and broad picture of the IRIS model 
nationally as well as the local context (South Gloucestershire, Manchester & 
Nottingham). The national IRIS reports provide an overall picture of the commissioned 
IRIS service across sites in England and Wales.  The data contained within the annual 
reports is captured, as part of the commissioning, by the AEs who are employed locally 
and therefore the assumption is made that the data is robustly monitored at source.  
In the original trial publication (Feder et al., 2011) acknowledgment was made of the 
difficulties in implementing the IRIS intervention in resource poor settings and indeed in 
the UK the scarcity of resources; funding, advocacy services and therefore specialist 
staff.  However, the documents show evidence of a growing number of commissioned 
IRIS programmes whereby as at 31st March 2016 33 IRIS sites were commissioned and 
running (31 in England and 2 in Wales).  These 33 commissioned sites cover 
appropriately 462 general practices who have undertaken all or some aspects of the IRIS 
training. To be clear 350 practices have undertaken all aspects of the IRIS training (2 
sessions per clinician and one for non-clinical staff) with a further 112 practices classed 
as partially IRIS trained at the end of 2015.The following map illustrates the range of 
areas covered in England and Wales.  
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It is also worthy of note that the rate of practices undertaking the IRIS programme 
shows no sign of slowing with data showing a 5 fold increase in take up of the IRIS 
programme since 2010 to 2015 (24 practices in the original trial to the current level of 
462 practices).  
The current 33 active IRIS sites cover a wide range of practices, both urban and rural 
although data was not provided on the number of patients covered across the 350 
practices. This would provide useful data in terms of the reach of the IRIS programme as 
well as some economic data against the number of referred patients to the AE per 
practice. This review has not included the detailed profile of the IRIS trained staff from 
the 462 practices, both clinical and administrative, that has engaged in the IRIS 
programme although the local providers and the national steering group do have access 
to this detailed and comprehensive data. Likewise data is available for the capture of 
referrals per level of staff (i.e. GP, practice nurse, health care assistant, receptionist 
etc.).  This type of data is valuable going forward for the national IRIS team in order to 
monitor the referral routes and how this might differ within primary care compared to 
the acute or other healthcare settings. Anecdotal evidence, obtained during this review, 
suggests that within primary care a culture exists whereby any DVA or safeguarding 
referral is only made in consultation with a GP or referred to a GP rather than practice 
staff acting directly.  This is despite the IRIS training and the NICE quality standards 
(2016) strongly stating that that all healthcare staff have a responsibility to refer and 
offer support for DVA.  
Furthermore, going forward referral data would enable targeted approaches by the 
commissioned advocacy services to actively target practices that are not referring or 
there is a slowing in referrals. Consideration needs to be given to the role of AEs and the 
clinical leads once practices are trained within the commissioned site. For example, in 
year 3 and 4 of the commissioned service emphasis should be placed on refresher 
training, further sessions offered for new or relocated staff to the site and a continual 
presence within the practices. A noted trend is that the IRIS programme is been 
commissioned on a short term basis, usually 12 – 24 months.   
The latest evidence provided in the 2015 national report indicates that seven (Camden, 
Hackney, Lambeth, Manchester, Nottingham City, Portsmouth and Southampton) of the 
twenty three current sites are operating into year 3 and 4 where referral rates are 
growing in momentum (2015 national report page 19). For example, in Nottingham City 
accumulative to the end of year 2 saw a total of 100 referrals whereas by year 3 this had 
increased to a total of 196 patient referrals; 96 referrals in year 3 alone.    
A known issue within primary care is the high level of movement within CCG areas of 
clinical staff, including the use of locum staff. This is an aspect that needs close 
monitoring by the local and national IRIS team if they are to ensure the continued rates 
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of patient referrals and management of DVA within primary care settings, particularly 
when so far commissioning of the IRIS programme is usually for an initial period of 12 – 
24 months. Of the 33 IRIS commissioned sites all but one have received extended 
funding although it is noted that this is often on a rolling programme and very often 
confirmed within 4 – 12 weeks of the funding expiring. This short term funding presents 
many challenges for the IRIS programme not least the uncertainty this creates for staff 
working within the programme and more widely the women that are receiving support.   
IRIS referral data 2013 -2016 
In conducting this review there was clear evidence of the effective tracking and 
monitoring of patients who were referred to the AEs across the 33 active IRIS areas.   
To be clear the number of referred patients only takes into account those patients who 
agreed or requested to be referred to the named AE for support. In cases where there is 
a recognised high risk or safeguarding issue the IRIS model is very clearly defined for 
referrals. For any staff in the practice they are able to contact their AE for specialist 
advice and for the AE to assess and refer high risk cases to MARAC.  Whilst this is not a 
24/7 service from the AE and is not intended to replace the normal safeguarding and 
crisis procedures in place within any general practice it does provide the specialist input 
and guidance to assess the level of risk.    
In terms of referral data this is obtained nationally from an established database 
accessed by all the AEs and advocacy services. In order to ensure consistency of 
recording data, advocacy services receive training on the IRIS programme including the 
training materials and data handling.  This includes the pre and post questionnaire data 
which is collected at the beginning and end of each training session (two sessions for 
clinicians and one session for practice admin staff).  The IRIS training programme for 
AEs is delivered by the National Implementation Manager and in 2014 the train the 
trainer programme was evaluated (see Taylor 2014 An Evaluation of the Train the 
Trainers Induction Course). Overall the feedback was very positive with 
recommendations implemented.  In addition to delivery of the IRIS training, each AE 
attends the initial IRIS training with twice yearly updates which are held around the UK.  
Graph 1 below shows the number of referrals nationally over time (blue line) and the 
increase in localities commissioning IRIS over time (red line).  
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Graph 1National IRIS patient referrals against trained localities 
 
A concern for any DVA intervention and advocacy service is capturing those patients who 
decide not to disclose DVA to a healthcare professional during a consultation but the 
patient later acts upon advice received, this can often be many months or even years 
afterwards. The nature and scope of contact with advocacy services is often difficult to 
capture often resulting in the true extent of support through the IRIS programme to go 
unrecognised.   
The IRIS programme is designed to allow practice staff to record any concerns or advice 
provided on the patient’s electronic medical records by way of a prompt for future 
consultations.  Initially this was through a newly developed pop-up template called 
HARKS.  The system has faced some difficulties and many practices are not accessing or 
utilising the HARK system instead opting to code patients under the current myriad of 
codes provided nationally for system 1.  
In addition to staff recording any DVA concerns on the patient records they have access 
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posters and “bra” cards.  This is in addition to the IRIS intervention materials such as 
posters and practice based leaflets. Within the DVA literature these are known issues 
particularly when trying to capture the true extent and prevalence of DVA.  This further 
emphasizes the complexities of providing and supporting survivors and families of DVA 
within any healthcare setting including primary care (Richardson et al., 2002, Hegarty, 
2006) and the acute setting (Hinsliff-Smith & McGarry 2016).  
The IRIS national data sets provide extensive and comprehensive demographic data 
about the 3093 patient referrals received by the AEs working across the 33 trained IRIS 
sites since 2010 and up to 30th June 2015. This not only includes useful data around age, 
gender, and ethnicity but a unique data set for the types of abuse experienced by those 
referred as well as the relationship to the perpetrator. This data is of national 
significance to the DVA community and those involved in providing support and advocacy 
services and should be made available in the national arena.  
SWOT analysis  
The analysis of the strengths, weaknesses, opportunities and threats of the national IRIS 
programme follows the review only of the available documents as described earlier in the 
report.  In addition, discussions with third sector specialist advocacy services were 
undertaken as well as CCG commissioners, two IRIS clinical leads, a public health 
consultant and four AEs. Each bullet point included in the SWOT have been described 
earlier in the report and aims to provide a succinct overview of the aspects that the IRIS 
national steering need to consider going forward. This SWOT should be viewed as a 
useful tool to aid the process of securing future funding and the impact of the IRIS 
intervention locally and nationally. 
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Strengths:  
- IRIS model uses established networks of 
DVA referral pathways 
- Programme links to NICE  (2014) 
guidelines & NICE (2016) quality standards  
- National capture of referral rates for 
commissioned areas 
 - Evidence of patient outcomes 
- Comprehensive evidence of the nature 
and type of DVA 
- Steering group membership 
- IRIS covers urban and rual practices 
- IRIS referals cover both genders 
- Extensive DVA data set for England 
- Proven DVA model 
- Programme is comprehensive offering 
three elements: training, patient markers, 
referral pathways 
- Regular updates for regional AEs  
- Robust demographic referral  data     
 
Weaknesses: 
- CCGs are not commisisinging IRIS 
routinely  
- CCG commisisoning is often short term 
(12 - 24 months) 
- Uncertainty about future funding for 
the IRIS model without DOH funding 
- Lack of cohesive plan to engage more 
CCGs and re-commissioning of IRIS 
- Limited effective dissemintaion of IRIS 
impact to front line staff (in surgeries) 
- Lack of planning for +3/4 year 
commisioned IRIS service 
- The current model of funding for AEs 
(this is based on practice numbers, not 
patients)  
- Time committment by practices to 
undertake the IRIS training 
- No robust data on practice staff and 
their role within practices (those that 
undertake the IRIS training) 
- Challenges faced by the national 
managers 
- Lack of web site updates and relevance 
to the public or healthcare professioanls 
Opportunities: 
- Proven model of DVA referral/support 
could be extended to other settings (i.e. 
ED, community nursing) 
- IRIS model could be tailored to deliver 
specialist training to medical schools and 
pre-reg training (nurses, midwives) 
- Raised public awareness of DVA 
- Media interest in DVA 
- NICE guidelines and Quality Standard 
(2016) 
- Goverment acknowledgment and 
committment by other public sectors (i.e. 
Police) to DVA 
- To expand and cover more urban/rual 
practices, some big cities covered 
- To include the voice of survivors  and 
those who have expereicned IRIS AE 
support 
- To develop IRIS materials for refresher 
training 
- A large data set of DVA prevalence and 
type of DVA from primary care settings 
Threats: 
- Lack of sustainable funding for current 
IRIS model 
- Reduction in advocacy services in 
England and therefore lack of specialist 
staff 
- DVA becomes subsumed under 
safeguarding so no need for IRIS model 
- Advocacy services (locally and 
nationally) are not able to cope with the 
influx of referrals  
- IRIS refresher training and 'mop 
up'sesisons for practices is not funded  
- Limited evidence  of public engagement  
locally or nationally to attract new 
funding 
- Limited evidence of service evaluations 
in the commissioned CCG areas 
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Challenges for the national IRIS model going forward? 
These are listed in no particular order and reflect the independent findings from the 
review of documents and discussions held with those involved in the IRIS programme. 
Continued funding –The IRIS programme was initially funded by the DOH for a period 
of 3 years with funding finishing in spring 2016. The National Steering group is 
considering the longer term funding requirements and how this may shape the IRIS 
programme going forward. Due consideration will need to be given to the operational 
aspects of the IRIS programme from a national perspective but also the leadership and 
direction of the IRIS programme which has received national recognition. Tied to the 
national funding picture, are the continual pressures faced by local CCGs often the 
commissioners for many healthcare services, including the IRIS programme. Short term 
funding appears to be an accepted norm for many third sector organisations and these 
often include the specialist DVA advocacy services.  
Wider reach of IRIS intervention programme – Whilst this aspect is presented in 
the SWOT as an opportunity, the national steering group will need to consider how best 
to diverse the successful, highly recognised and proven DVA model outside of general 
practice. The recent NICE quality standards (2016) places the IRIS programme in an 
excellent position and conduit for meeting many aspects of the NICE (2016) quality 
standards across a vast array of healthcare settings.  The national steering group 
therefore needs to carefully consider its position going forward and how it may meet the 
challenges of a diversification of the IRIS programme.  
Going forward - The IRIS programme is embedded into 450 general practices the task 
for the national steering group is to consider the timescales and realistic expectations for 
the next 3 – 5 years within general practice.  Do the national steering group have a clear 
vision for the next 3 - 5 years with strategic goals and aspirations?  
Limitations 
This independent review is solely based on the materials provided by the IRIS national 
steering along with other independent commissioned service evaluations and user 
engagement reports.  
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